Literature DB >> 11821424

Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells.

Jianwu Xie1, Matthew J LeBaron, Marja T Nevalainen, Hallgeir Rui.   

Abstract

Genetic studies in mice have established a critical role for prolactin receptors and transcription factor Stat5 in mammary gland differentiation. However, the enzymatic coupling between prolactin receptors and Stat5 in this process has not been established. In addition to Jak2, several other tyrosine kinases reportedly also are associated with prolactin receptors and may phosphorylate Stat5. Because Jak2 null mice die in utero, we targeted Jak2 in an ex vivo model of prolactin-induced mammary epithelial cell differentiation to determine the role of Jak2 in regulation of cell differentiation and growth. Two independent targeting strategies were used to suppress Jak2 in immortalized HC11 mouse mammary epithelial cells: 1) stable expression of a specific Jak2 antisense construct and 2) adenoviral delivery of a dominant-negative Jak2 gene. We now demonstrate that Jak2 is essential for prolactin-induced differentiation and activation of Stat5 in normal mouse mammary epithelial cells. Furthermore, suppression of Jak2 in HC11 cells was associated with constitutive activation of oncoprotein Stat3 and a hyperproliferative phenotype characterized by increased mitotic rate, reduced apoptosis, and reduced contact inhibition. Collectively, our data suggest that Jak2 is differentiation-inducing and growth-inhibitory in normal mammary epithelial cells, observations that may shed new light on the role of the Jak2-Stat5 pathway in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821424     DOI: 10.1074/jbc.M112399200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Identification of PKCzetaII: an endogenous inhibitor of cell polarity.

Authors:  Scott J Parkinson; J Anne Le Good; Richard D H Whelan; Phil Whitehead; Peter J Parker
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

2.  Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Authors:  Amy R Peck; Agnieszka K Witkiewicz; Chengbao Liu; Ginger A Stringer; Alexander C Klimowicz; Edward Pequignot; Boris Freydin; Thai H Tran; Ning Yang; Anne L Rosenberg; Jeffrey A Hooke; Albert J Kovatich; Marja T Nevalainen; Craig D Shriver; Terry Hyslop; Guido Sauter; David L Rimm; Anthony M Magliocco; Hallgeir Rui
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

3.  PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.

Authors:  Kevin J Johnson; Amy R Peck; Chengbao Liu; Thai H Tran; Fransiscus E Utama; Ashley B Sjolund; John D Schaber; Agnieszka K Witkiewicz; Hallgeir Rui
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

4.  Nuclear Jak2 and transcription factor NF1-C2: a novel mechanism of prolactin signaling in mammary epithelial cells.

Authors:  Jeanette Nilsson; Gunnar Bjursell; Marie Kannius-Janson
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

5.  ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo.

Authors:  Rebecca S Muraoka-Cook; Melissa A Sandahl; Karen E Strunk; Leah C Miraglia; Carty Husted; Debra M Hunter; Klaus Elenius; Lewis A Chodosh; H Shelton Earp
Journal:  Mol Cell Biol       Date:  2009-07-13       Impact factor: 4.272

6.  SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.

Authors:  Timothy M Piazza; Juu-Chin Lu; Kristopher C Carver; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2008-12-04

Review 7.  Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

Authors:  Shyh-Han Tan; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

8.  Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation.

Authors:  Rebecca S Muraoka-Cook; Melissa Sandahl; Debra Hunter; Leah Miraglia; H Shelton Earp
Journal:  Mol Endocrinol       Date:  2008-07-24

9.  Image-based evaluation of the molecular events underlying HC11 mammary epithelial cell differentiation.

Authors:  Liang Shan; Renshu Zhang; Wanghai Zhang; Edward Lee; Rajagopalan Sridhar; Elizabeth G Snyderwine; Paul C Wang
Journal:  Anal Biochem       Date:  2008-08-08       Impact factor: 3.365

10.  Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.

Authors:  Yunfei Wen; Behrouz Zand; Bulent Ozpolat; Miroslaw J Szczepanski; Chunhua Lu; Erkan Yuca; Amy R Carroll; Neslihan Alpay; Chandra Bartholomeusz; Ibrahim Tekedereli; Yu Kang; Rajesha Rupaimoole; Chad V Pecot; Heather J Dalton; Anadulce Hernandez; Anna Lokshin; Susan K Lutgendorf; Jinsong Liu; Walter N Hittelman; Wen Y Chen; Gabriel Lopez-Berestein; Marta Szajnik; Naoto T Ueno; Robert L Coleman; Anil K Sood
Journal:  Cell Rep       Date:  2014-04-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.